Nektar Therapeutics · NASDAQ:NKTR
Susquehanna Portfolio Strategies, LLC reported a 6.30% stake in Nektar Therapeutics (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 13, 2025
Susquehanna Portfolio Strategies, LLC reported a 6.30% stake in Nektar Therapeutics, 1,235,864 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 1,235,864
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Susquehanna Portfolio Strategies, LLC | 6.30% | 1,235,864 |
| Susquehanna Securities, LLC | 6.30% | 1,235,864 |
Source
Related
- Nektar Therapeutics
- G1 Execution Services, LLC
- Nektar Therapeutics shareholders
- Schedule 13G/A · G1 Execution Services, LLC · Feb 13, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026